Author

Kimberly Gentile

Observed name: Gentile, Kimberly

Institution: Biohaven Pharmaceuticals (United States)

Observed institution: Biohaven Pharmaceuticals (United States)

OpenAlex ID: A5082661205

Next Generation Prodrug Troriluzole: Increased Bioavailability of Riluzole with No Food Effect in Healthy Subjects (S5.006)

2024 · Heather Sevinsky, Rachel Rozakis, et al. · Neurology · 1

A Phase 1 Study to Evaluate Bioequivalence Between BHV-0223 40 mg Zydis® Sublingual Formulation and Riluzole 50 mg Oral Tablet in Healthy Volunteers (S5.005)

2019 · Irfan A. Qureshi, Vladimir Coric, et al. · Neurology · 1

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Rising Doses of a Next Generation Prodrug Troriluzole in Healthy Subjects (P4-4.012)

2024 · Heather Sevinsky, Bharat Awsare, et al. · Neurology

10 students arrested in protest: Lack of AAS decision sparks student action

1999 · Gentile, Kimberly · Texas ScholarWorks (Texas Digital Library)

Students, provost discuss program

1999 · Gentile, Kimberly · Texas ScholarWorks (Texas Digital Library)

Protesters, UT officials find no common ground at meeting

1999 · Gentile, Kimberly · Texas ScholarWorks (Texas Digital Library)

New degree could start in fall 2000

1999 · Gentile, Kimberly · Texas ScholarWorks (Texas Digital Library)

Works count: 7

Citation count: 2

H-index: 1

I10-index: